Tariff news has led to a volatile stock market over the past few months, but retail investors have been happy to use that as ...

Future Pak would not require a financing contingency in connection with a transaction and has the full support of its strategic financial partner, Colbeck Capital Management. Read Next ...

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company’s marketed ...

With an impressive -0.98% ROE, the company effectively utilizes shareholder equity capital. Return on Assets (ROA): Vanda Pharma's ROA excels beyond industry benchmarks, reaching -0.82%.